About: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.73 (-4.95%)
Status: deslistada — removed_from_provider. Este ativo não é mais negociado; são exibidos dados históricos.
OSTXNYSEOS Therapies Incorporated
Carregando status da lista de acompanhamento…
OS Therapies Incorporated share price
OSTX price activity
Último preço
Variação (24h)
USD (%)
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/A
Último negócio
OSTX price performance
0%
5D
0%
1M
23,57%
YTD
-17,22%
1Y
OSTX price fundamentals
N/D
Shares Issued
N/D
Earnings Per Share (EPS)
N/D
Dividends Per Share (DPS)
N/D
P/E Ratio
Price market cap
Cap. de mercado
N/A
Ranking em US-NYSE
N/ARanking do setor
N/AOSTX details
quote.marketSignals